Newsroom
May 25, 2023
From social media to ads featuring an earworm jingle, it’s hard to escape hearing about Ozempic. Hailed for its game-changing effect on diabetes and obesity, semaglutide, the generic medication sold under the brand name Ozempic, is now being studied for its effectiveness on another deadly disease — Alzheimer’s. The Glenn Biggs Institute for Alzheimer’s and […]
May 23, 2023
Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in partnership with The University of Texas Rio Grande Valley, is Texas’ […]
May 22, 2023
Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 22, 2023) — Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in […]
May 18, 2023
Sudha Seshadri, MD, professor, Neurology, founding director, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this story. Read More
May 18, 2023
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
May 10, 2023
William L. Henrich, MD, MACP, president, UT Health San Antonio, and Sudha Seshadri, MD, professor, Neurology and founding director, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. and Carlayne Jackson, MD, Neurology, were quoted in this story. The story also includes a video of an interview with Alicia Parker, MD, Neurology and Okeanis Vaou, MD, […]